Archive - August 2017

An analysis of data collected as part of the Women’s Health Initiative (WHI) trial has found that postmenopausal women who use vaginal estrogen have the same risk of invasive breast cancer, stroke, blood clots, endometrial cancer, and colorectal cancer as women who don’t use vaginal estrogen. The research was published online on Aug. 14, 2017 by the journal Menopause. Read the abstract of “Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal

Several large studies, including a review by the U.S. Preventive Services Task Force in 2009 and a study on the causes of death in the United Kingdom in 2013, have questioned the value of screening mammograms. Doctors who question the value of mammograms say that while mammograms do save lives, for each breast cancer death prevented, three to four women are overdiagnosed. Overdiagnosis means either: a screening mammogram finds a suspicious area that would have been eventually diagnosed as

A class of drugs known as CDK4/6 inhibitors, which have been approved for treating some types of breast cancer, may have much more to offer than previously thought. Not only can they stop tumors from growing by halting cell division, but they can also "spur the immune system to attack and shrink" them. This was the main finding of a new study from the Dana-Farber Cancer Institute and Brigham and Women's Hospital, both in Boston, MA, the results of which have been published in the journal

It sounds counterintuitive, but a new study shows that the side effects of a chemotherapy drug may enable breast cancer to spread. Breast cancer survival rates have consistently been improving in recent years, and much of the progress is due to the effectiveness of chemotherapy. However, previous studies have suggested that a chemotherapy treatment in breast cancer may have a counterintuitive effect, instead raising the risk of metastasis. Earlier this year, one such study showed that

A review of the latest scientific research on breast cancer shows that there is strong evidence that breast-feeding can reduce women's risk of premenopausal and postmenopausal breast cancers. A report on the review, by the American Institute for Cancer Research (AICR) and the World Cancer Research Fund (WCRF), has been released this week to mark World Breastfeeding Week. The report offers several possible explanations for how breast-feeding lowers breast cancer risk. One reason is that

Success as an HME compression provider takes commitment, education and an understanding that there is more to compression beyond the feet. The compression sock is an integral product to carry for any HME provider committed to using compression technology to help patients. Compression doesn’t even need to be required due a medical condition – it’s an almost universal need. Sitting or standing for excessive amounts of time can be terrible for your health, especially the feet. For

As president and CEO of the Lymphatic Education and Research Network William Repicci wants to ensure patients and providers have all information on lymphedema, lipedema and lymphatic or venous disease that they need. William Repicci is the president and CEO of the Lymphatic Education and Research Network (LE&RN), which you can visit at lymphaticnetwork.org. The organization focuses on lymphatic education and advocacy and offers extensive information on lymphedema, lipedema and lymphatic or venous